Diabetic patients taking GLP-1 instead of insulin have a lower risk of cancer
Type 2 diabetes patients taking GTP-1 drugs, including Ozempic, have a lower risk of developing 10 obesity-related cancers than those taking insulin and other diabetes medications, according to a study published Friday.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG